E-viri
Recenzirano
Odprti dostop
-
Oruc, Aysegul; Sumnu, Abdullah; Turkmen, Aydın; Basturk, Taner; Cebeci, Egemen; Turgutalp, Kenan; Cetinkaya, Hakkı; Uzerk Kibar, Müge; Seyahi, Nurhan; Tatar, Erhan; Ergul, Metin; Derici, Ülver; Aylı, Mehmet Deniz; Pınar, Musa; Bakar, Betül; Kazancıoglu, Rümeyza; Yıldız, Abdülmecit; Dirim, Ahmet Burak; Yılmaz, Zülfükar; Turkmen, Kültigin; Tunca, Onur; Koc, Mehmet; Kutlay, Sim; Micozkadıoglu, Hasan; Azak, Alper; Boztepe, Burcu; Ustundag, Sedat; Şafak Ozturk, Seda; Unsal, Abdulkadir; Karadag, Serhat; Sahin, Gülizar; Yenigun, Ezgi Coşgun; Eren, Necmi; Gullulu, Mustafa; Gursu, Meltem; Ozturk, Savaş
Renal failure 46, Številka: 1Journal Article
Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore, we aimed to investigate IST results among IgAN patients in Turkiye. The data of 1656 IgAN patients in the Primary Glomerular Diseases Study of the Turkish Society of Nephrology Glomerular Diseases Study Group were analyzed. A total of 408 primary IgAN patients treated with IST (65.4% male, mean age 38.4 ± 12.5 years, follow-up 30 (3-218) months) were included and divided into two groups according to treatment protocols (isolated corticosteroid CS 70.6% and combined IST 29.4%). Treatment responses, associated factors were analyzed. Remission (66.7% partial, 33.7% complete) was achieved in 74.7% of patients. Baseline systolic blood pressure, mean arterial pressure, and proteinuria levels were lower in responsives. Remission was achieved at significantly higher rates in the CS group (78% 66.7%, = 0.016). Partial remission was the prominent remission type. The remission rate was significantly higher among patients with segmental sclerosis compared to those without (60.4% 49%, = 0.047). In the multivariate analysis, MEST-C S1 (HR 1.43, 95% CI 1.08-1.89, = 0.013), MEST-C T1 (HR 0.68, 95% CI 0.51-0.91, = 0.008) and combined IST (HR 0.66, 95% CI 0.49-0.91, = 0.009) were found to be significant regarding remission. CS can significantly improve remission in high-risk Turkish IgAN patients, despite the reliance on non-quantitative endpoints for favorable renal outcomes. Key predictors of remission include baseline proteinuria and specific histological markers. It is crucial to carefully weigh the risks and benefits of immunosuppressive therapy for these patients.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.